MINOZ 100

Product Details:

Drug Type Generic Drugs
Ingredients MINOCYCLINE 100
Physical Form Tablets
Function Antibiotic Medicine
Recommended For BACTERIL INFECTION LUNG,U.T.I,,ACNE
Suitable For Suitable For All
Quantity 50 Boxes
Share Your Product:

51.91-56.01 USD ($)/Box

Get a Price/Quote

Request To Call Back Send Inquiry

MINOZ 100 Price And Quantity

Minimum Order Quantity 5 Box
Price 51.91-56.01 USD ($)/Box

MINOZ 100 Product Specifications

Suitable For Suitable For All
Physical Form Tablets
Recommended For BACTERIL INFECTION LUNG,U.T.I,,ACNE
Function Antibiotic Medicine
Drug Type Generic Drugs
Ingredients MINOCYCLINE 100
Quantity 50 Boxes
Storage Instructions ROOM TEMP. 10 -30 C

MINOZ 100 Trade Information

Payment Terms Cash in Advance (CID)
Supply Ability 100 Box Per Week
Delivery Time 2 Week
Sample Policy Sample costs shipping and taxes has to be paid by the buyer
Packaging Details 1*10*10/BOX
Main Export Market(s) Australia North America Eastern Europe Middle East Africa Central America South America Asia Western Europe
Main Domestic Market All India

Product Description

Other Details

In Treatment of Bacterial infections

Minoz 100 Tablet is an antibiotic medicine which can be used to treat many different infections caused by bacteria. It stops the growth of the bacteria causing the infection and clears the infection. Take it for as long as prescribed by the doctor and avoid skipping doses. This will make sure that all bacteria are killed and they do not become resistant.

SIDE EFFECTS OF MINOZ TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you are worried about them

Common side effects of Minoz

Headache

Dizziness

Photosensitivity

Vomiting

Nausea

Itching

Diarrhea

HOW TO USE MINOZ TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Minoz 100 Tablet may be taken with or without food, but it is better to take it at a fixed time.

HOW MINOZ TABLET WORKS

Minoz 100 Tablet is an antibiotic. It stops bacterial growth by preventing synthesis of essential proteins required by bacteria to carry out vital functions.

Other Products in 'Pharmaceutical Tablets' category

LEDIPASVIR+SOFOSUVIR TAB Price : 252.81-266.48 USD ($)/Bottle Minimum Order Quantity : 2 Quantity : 10 Unit Storage Instructions : ROOM TEMP. 10 30 C Function : Cure Liver Drug Type : Specific Drug Ingredients : Ledipasvir (90mg) + Sofosbuvir (400mg) Suitable For : Women, Adults Physical Form : Tablets Recommended For : Chronic hepatitis C virus (HCV) infection Dosage : Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.

Send Inquiry

BDRON 500MG Tablets Price : 170.71-177.53 USD ($)/Bottle Minimum Order Quantity : 3 Quantity : 10 Unit Storage Instructions : ROOM TEMP. 10 30 C Function : Cancer Treatment Drug Type : Specific Drug Ingredients : ABIRATERONE Suitable For : Aged Person Physical Form : Tablets Recommended For : Prostate Cancer Dosage : Prostate Cancer Metastatic castrationresistant prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic castrationresistant prostate cancer (CRPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Yonsa Indicated in combination with methylprednisolone for the treatment of patients with metastatic CRPC 500 mg (four 125mg tablets) PO qDay in combination with methylprednisolone 4 mg PO BID

Send Inquiry

Abiraterone Acetate 250mg Price : 259.59-273.26 USD ($)/Bottle Minimum Order Quantity : 3 Quantity : 5 Boxes Storage Instructions : ROOM TEMP. 10 30 C Function : Cancer Treatment Drug Type : Specific Drug Ingredients : ABIRATERONE 250 Suitable For : Adults, Aged Person Physical Form : Tablets Dosage : Prostate Cancer Metastatic castrationresistant prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic castrationresistant prostate cancer (CRPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Yonsa Indicated in combination with methylprednisolone for the treatment of patients with metastatic CRPC 500 mg (four 125mg tablets) PO qDay in combination with methylprednisolone 4 mg PO BID Metastatic highrisk castrationsensitive prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic highrisk castrationsensitive prostate cancer (CSPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Dosage Modifications Strong CYP3A4 inducers Coadministration with strong CYP3A4 inducers (eg, phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital): Avoid if possible; if strong CYP3A4 inducer must be administered, increase abiraterone dosage frequency of abiraterone Reduce dose back to the previous dose and frequency, if the concomitant strong CYP3A4 inducer is discontinued Yonsa Increase from 500 mg qDay to 500 mg BID Zytiga Increase from 1000 mg qDay to 1000 mg BID Hepatic impairment (Zytiga) Baseline LFTs Mild (ChildPugh A): No dosage adjustment necessary Moderate (ChildPugh B): Reduce starting dose to 250 mg PO qDay; monitor ALT, AST, and bilirubin prior to start of treatment, qWeek for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment, discontinue abiraterone and do not retreat patients Severe (ChildPugh C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN: Interrupt treatment; reinitiate at reduced dose of 750 mg PO qDay following return of LFTs to baseline or to AST/ALT ≤2.5x ULN and total bilirubin ≤1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs at 750 mg/day, may restart at 500 mg/day (after LFTs decrease as above) If hepatoxicity recurs at reduced dose of 500 mg/day, discontinue treatment Permanently discontinue treatment for patients who develop a concurrent elevation of ALT >3x ULN and total bilirubin >2x ULN in the absence of biliary obstruction or other causes responsible for the concurrent elevation Hepatic impairment (Yonsa) Baseline Moderate (ChildPugh Class B): Reduce 125 mg PO qDay; monitor ALT, AST, and bilirubin prior to the start of treatment, every week for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment: Discontinue treatment and do not retreat patients with abiraterone Severe (ChildPugh Class C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN): Interrupt treatment; restart at a reduced dose of 375 mg qDay following return of liver function tests to the patient’s baseline or to AST and ALT ≤2.5x ULN and total bilirubin ≤1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs on 375 mg/day, may be restart aeduced dose of 250 mg/day (after LFTs decrease as above) I

Send Inquiry

EVEROLIMUS 10 Price : 191.18-198.01 USD ($)/Box Minimum Order Quantity : 2 Quantity : 10 Boxes Storage Instructions : ROOM TEMP. 10 30 C Function : Other Drug Type : Generic Drugs Ingredients : EVEROLIMUS 10 Suitable For : Women, Adults, Aged Person Physical Form : Tablets Recommended For : Prevention of organ rejection in transplant patients Treatment of Breast cancer Treatment of Pancreatic cancer Treatment of Lung cancer Treatment of Kidney cancer

Send Inquiry

SEND INQUIRY CALL ME FREE